Auroa Badin is a Cardiology physician affiliated with OhioHealth. OpenAlex indexes 73 publications with 227 citations (h-index 8).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Industry payments
12 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Boston Scientific CorporationProgram year202567 payments$40,261openpaymentsdata.cms.gov ↗
- Biosense Webster, Inc.Program year202527 payments$19,891openpaymentsdata.cms.gov ↗
- Philips North America LLCProgram year202517 payments$12,964openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
61.1%Antiarrhythmic31.2%Amiodarone Hcl37%Flecainide Acetate36%Dofetilide21%Propafenone Hcl4%Quinidine Sulfate3%Part D<11 patientsBeta blocker19.6%Metoprolol Succinate46%Metoprolol Tartrate27%Sotalol16%Propranolol Hcl Er7%Carvedilol4%Part D<11 patients+ 4 more classes in this area
Blood & clotting
35.9%Factor Xa inhibitor32.9%Eliquis77%Xarelto23%Part D≥116 patientsDirect thrombin inhibitors1.6%Dabigatran Etexilate100%Part D≥11 patients+ 1 more class in this area
Metabolism & gastrointestinal
3%Proton pump inhibitor1.9%Pantoprazole Sodium100%Part D≥24 patientsPotassium supplement1.1%Potassium Chloride100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Pulsed Field Ablation as Initial Therapy for Persistent Atrial Fibrillation
New England Journal of Medicine
2026 - Insights Into Early Adoption and Physician Learning Curve of Pulsed Field Ablation in the United States
Circulation Arrhythmia and Electrophysiology
2025 - Learning curve of pulsed field ablation for atrial fibrillation: insights from a United States center
Journal of Interventional Cardiac Electrophysiology
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Yvonne Efebera, MD
OhioHealth
Gary Ansel, MD
OhioHealth
Michael A. Becker
OhioHealth
George R. Simon
OhioHealth
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Scott Solomon, MD
Brigham and Women's Hospital
Eric Topol, MD
Scripps Research Institute (Scripps Research)
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”